Sort
130,381 grants matching “hiv”
Functional Genomics Laboratory (FGL)
$1,077,845Anton Simeonov · National Center For Advancing Translational Sciences · ZIC · FY2022 · TR
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
$1,077,827Marianna K Baum · Florida International University · U01 · FY2019 · DA
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
$1,077,827Marianna K Baum · Florida International University · U01 · FY2018 · DA
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
$1,077,827Marianna K Baum · Florida International University · U01 · FY2017 · DA
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
$1,077,827Marianna K Baum · Florida International University · U01 · FY2020 · DA
GLOBAL HIV VACCINE ENTERPRISE
$1,077,813Bill Snow · Global Hiv Vaccine Enterprise · N01 · FY2013 · AI
Prevention of HIV Infection in High-Risk Social Networks of African American MSM
$1,077,809Jeffrey A. Kelly · Medical College Of Wisconsin · R01 · FY2011 · MH
Vaccine development and production
$1,077,795Sylvain Fleury · University Of Louisiana At Lafayette · U19 · FY2021 · AI
Use of ARV Drug Levels in DBS to Assess and Manage ART Adherence in South Africa
$1,077,794Robert H Remien · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2017 · AI
UCSF Older Americans Independence Center
$1,077,688Kenneth E. Covinsky · University Of California, San Francisco · P30 · FY2018 · AG
Molecular Epidemiology Studies of Occupational and Environmental Exposures
$1,077,584Nathaniel Rothman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
Effects of systemic and topical perturbations on human microbes
$1,077,460Heidi Kong · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$1,077,403Roger L Shapiro · Harvard School Of Public Health · U01 · FY2018 · AI
Signal Pathways Modulating HIV-1-induced Injury in CNS
$1,077,378Temple University · P01 · FY2002 · NS
Transmissibility of GC and Ct Diagnosed using NAAT
$1,077,314Research Triangle Institute · R01 · FY2003 · HD
CoVPN 3001 A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine LC3
$1,077,287Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Developmental
$1,077,259Ann Cornwall Collier · University Of Washington · P30 · FY2009 · AI
Seattle Clinical Trials Unit
$1,077,209Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Molecular Genetics Of Mammalian Retrovirus Replication
$1,077,137Judith G Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
$1,077,090Smriti Mehra · Texas Biomedical Research Institute · R01 · FY2020 · AI
Women and Infants Transmission Study IV - Chicago
$1,077,067University Of Illinois At Chicago · U01 · FY2001 · AI
NATURAL HISTORY OF MENOPAUSE IN HIV INFECTED DRUG USERS
$1,077,063Montefiore Medical Center (Bronx, Ny) · R01 · FY2002 · DA
New targets against tuberculosis
$1,076,804Deborah T Hung · Broad Institute, Inc. · R01 · FY2021 · AI
Molecular profile of proviral reservoirs in HIV-infected drug users
$1,076,786Xu Yu · Massachusetts General Hospital · R61 · FY2019 · DA
Five Point Initiative: A Cluster Randomized Trial of a Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
$1,076,776Sannisha K. Dale · University Of Miami Coral Gables · R01 · FY2024 · MH